SkinVision

SkinVision Medical service that empowers people to take a more active role in their skin’s health.

Used by 2M+ people worldwide to assess the risk for the most common types of skin cancer.

24/03/2026

Spring sun, soft light,
But UVA still bites ☀️

UVA rays are present all year round, even on cloudy spring days. They pe*****te deeper into the skin and quietly contribute to premature aging and long term skin damage.

Are you back to sunscreen season?

Comment ☀️ if yes, 🌤️ if you just remembered.

In clinical affairs, progress is defined by evidence, not momentum.As our Head of Clinical Affairs, explains, this resea...
23/03/2026

In clinical affairs, progress is defined by evidence, not momentum.

As our Head of Clinical Affairs, explains, this research collaboration supports the generation of robust clinical evidence as part of our U.S. regulatory pathway.

From a clinical perspective, performance evaluation, defined intended use, and rigorous methodology are essential before broader deployment. This pivotal study contributes to that evidence base, ensuring our AI-powered skin health assessment is evaluated responsibly within the U.S. healthcare context.

Advancing digital health requires scientific discipline. That is the standard guiding this initiative.

Disclosure: Mayo Clinic has a financial interest in the technology referenced and will use any revenue received to support its not-for-profit mission in patient care, education and research.

Skin cancer in the United States is not only a growing concern in numbers.It is also a matter of access.Workforce shorta...
20/03/2026

Skin cancer in the United States is not only a growing concern in numbers.

It is also a matter of access.

Workforce shortages and system-level barriers can delay timely evaluation. When evaluation is postponed, outcomes may be affected.

We are supporting responsible, research-backed solutions that expand access to skin health guidance and encourage earlier engagement. These efforts are designed to complement professional medical care, not replace it.

As our CEO shares, this research collaboration supports the continued development of clinical evidence behind our AI-bas...
18/03/2026

As our CEO shares, this research collaboration supports the continued development of clinical evidence behind our AI-based skin health assessment.

The study is designed to evaluate performance and intended use within the U.S. healthcare context as part of our broader regulatory pathway.

Advancing digital health requires rigorous evaluation, transparency, and alignment with established clinical standards. This research represents a structured step toward strengthening evidence-led skin health guidance in the United States.

Disclosure: Mayo Clinic has a financial interest in the technology referenced and will use any revenue received to support its not-for-profit mission in patient care, education and research.

Read the full announcement → https://www.skinvision.com/press-release/skinvision-collaborates-on-pivotal-trial-to-improve-access-to-dermatology-care-in-the-united-states

We’ve announced a clinical research collaboration with to support a U.S. FDA pivotal trial for SkinVision.The collabor...
16/03/2026

We’ve announced a clinical research collaboration with to support a U.S. FDA pivotal trial for SkinVision.

The collaboration focuses on the exchange of clinical, scientific, and technological know-how, and includes research activities intended to inform the responsible development and evaluation of digital skin health solutions in the United States.

We look forward to sharing progress as this collaboration advances.

Disclosure: Mayo Clinic has a financial interest in the technology referenced and will use any revenue received to support its not-for-profit mission in patient care, education and research.

Read the full announcement -> https://www.skinvision.com/press-release/skinvision-collaborates-on-pivotal-trial-to-improve-access-to-dermatology-care-in-the-united-states

We’ve announced a clinical research collaboration with to support a U.S. FDA pivotal trial for SkinVision.The collabor...
16/03/2026

We’ve announced a clinical research collaboration with to support a U.S. FDA pivotal trial for SkinVision.

The collaboration focuses on the exchange of clinical, scientific, and technological know-how, and includes research activities intended to inform the responsible development and evaluation of digital skin health solutions in the United States.

We look forward to sharing progress as this collaboration advances.

Disclosure: Mayo Clinic has a financial interest in the technology referenced and will use any revenue received to support its not-for-profit mission in patient care, education and research.

Read the full announcement. Link in bio.

15/03/2026

Skin cancer incidence continues to rise in the United States.
Yet access to dermatologic care remains uneven, shaped by workforce shortages, insurance barriers, and geography. Digital health has an important role to play but only when built and evaluated responsibly.

Sources:
American Academy of Dermatology
Skin Cancer Foundation
HRSA Workforce Data

Spring is back. And so is everyday sun exposure.Even on mild days, UV can still reach your skin. That’s why small habits...
14/03/2026

Spring is back. And so is everyday sun exposure.
Even on mild days, UV can still reach your skin. That’s why small habits matter.
After a sunny day outside, take a quick moment to check your skin.

It only takes a minute, and it can bring real peace of mind.

Which one did you do this weekend?

Wondering what happens when you scan a spot with SkinVision?Here’s how it works:• Image analysed via clinically validate...
12/03/2026

Wondering what happens when you scan a spot with SkinVision?

Here’s how it works:
• Image analysed via clinically validated algorithm
• Risk level assessment
• Clear recommendation on next steps

SkinVision is certified as a Class IIa medical device under the European MDR.

It doesn’t replace a clinical diagnosis. It supports early awareness and helps you decide when to take the next step.

Follow SkinVision for more insights on early skin health and digital prevention.



10/03/2026

In this , we hear from Ralf, a father whose life changed because of one quiet moment and one small spot.

Ralf didn’t think much of the spot on his neck, until a gentle nudge (from his daughter and the SkinVision app) led him to a diagnosis he didn’t expect: melanoma.

What started as a maybe later moment became the decision that changed everything.

This is your reminder: the warning signs aren’t always loud.
Sometimes, it’s that quiet voice telling you to just check.

📲 Watch the full story → https://youtu.be/p3CPp0ppH9E

Skin cancer doesn’t discriminate.Not by age, not by fame, not even by how healthy you feel.This Women’s Day, we’re highl...
09/03/2026

Skin cancer doesn’t discriminate.
Not by age, not by fame, not even by how healthy you feel.

This Women’s Day, we’re highlighting women who used their voice to turn a difficult diagnosis into awareness. Their stories remind us that skin cancer often starts small, quietly, and can happen to anyone.

Save this post as a reminder to check your skin regularly, and share it with a woman in your life who deserves that reminder too. 💙

New season, fresh routines 💐Taking a minute to check in with your skin can make awareness easier over time.Scan your spo...
06/03/2026

New season, fresh routines 💐
Taking a minute to check in with your skin can make awareness easier over time.

Scan your spots with SkinVision

Save this for your next skin check and Follow SkinVision for practical skin reminders

Adres

Kraanspoor 28
Amsterdam
1033SE

Website

Meldingen

Wees de eerste die het weet en laat ons u een e-mail sturen wanneer SkinVision nieuws en promoties plaatst. Uw e-mailadres wordt niet voor andere doeleinden gebruikt en u kunt zich op elk gewenst moment afmelden.

Contact De Praktijk

Stuur een bericht naar SkinVision:

Snelkoppelingen

Uitgelicht

Delen

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Type

Our Story

While more resources for skin cancer and treatment exist today than ever, the number of new skin cancer cases is increasing and becoming more of a health epidemic.

Globally, one in five people will develop skin cancer at some point in their lives, and that number increases to two out of three people in countries such as New Zealand and Australia. Because skin cancer can grow slowly and go unnoticed, it is important to track skin spots carefully.

SkinVision’s CE certified app empowers individuals to monitor their skin spots for the early signs of skin cancer. The user takes a photo of their skin spot and within 30 seconds they receive a risk indication (low-low with symptoms-high), and a recommendation on the next steps to take.

The accuracy of the algorithm been clinically-validated in several studies. Most recently, a study published in a peer-reviewed journal concluded that the SkinVision app has a high accuracy of detecting skin cancer. The overall sensitivity of the algorithm in recognising skin cancer (melanoma, BCC, SCC and premalignant stages) is 95.1%.